
Current Price | $19.28 | Mkt Cap | $6.3B |
---|---|---|---|
Open | $19.06 | P/E Ratio | 40.84 |
Prev. Close | $19.28 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $18.99 - $19.38 | Volume | 3,431,214 |
52-Wk Range | $14.87 - $22.47 | Avg. Daily Vol. | 2,977,683 |
A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases.
Current Price | $19.28 | Mkt Cap | $6.3B |
---|---|---|---|
Open | $19.06 | P/E Ratio | 40.84 |
Prev. Close | $19.28 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $18.99 - $19.38 | Volume | 3,431,214 |
52-Wk Range | $14.87 - $22.47 | Avg. Daily Vol. | 2,977,683 |
The best Bull and Bear pitches based on recency and number of recommendations.
Strong revenue growth and a oncology portfolio that is growing.
This sector is a scary one! Fear, though, is a fools game. I don't expect this stock to move upwards in the very near future. The cash burn is, well, similar to that Texas A&M bonfire tradition.
Read the most recent pitches from players about EXEL.
Recs
Strong revenue growth and a oncology portfolio that is growing.
Recs
From Fidelity or Zacks November 2021:
Revenue Growth (Last 5 Years) = 92.7%
Revenue % Change (Last Qrtr VS. Same Qrtr Prior Year) = 42.1%
Price/Sales (TTM) = 5.2
Recs
First one i picked all by myself, reason:
1. Mkt Cap 7.39B plenty place to grow
2. EPS nxt Yr 94.84%
3.EPS nxt 5Yr 46.00%
4. Sales past 5Yr 107.60%
5. Dept/ Equity 0
Issues:
1. High insider transactions almost 30%
2. Company works on cure for cancer - high volatility
3. EPS this Y -53.80% but justified by Covid-19
Practice and enjoy!
Find the members with the highest scoring picks in EXEL.
beave35 (91.90) Score: +1,282.31
The Score Leader is the player with the highest score across all their picks in EXEL.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
Playa14 | < 20 |
|
![]() |
5Y | $1.27 | +1,418.11% | +100.35% | +1,317.76 | 0 Comment | |
beave35 | 91.90 | 12/23/2014 |
![]() |
5Y | $1.30 | +1,382.96% | +100.65% | +1,282.31 | 0 Comment | |
tomkao | < 20 | 12/15/2014 |
![]() |
5Y | $1.40 | +1,277.14% | +107.03% | +1,170.11 | 0 Comment | |
jack0071 | 66.47 | 12/3/2014 |
![]() |
5Y | $1.43 | +1,248.25% | +101.32% | +1,146.93 | 0 Comment | |
portefeuille | 98.39 |
|
![]() |
NS | $1.44 | +1,238.89% | +106.62% | +1,132.26 | 0 Comment | |
akoniec | 23.69 | 10/9/2014 |
![]() |
3Y | $1.55 | +1,143.87% | +112.57% | +1,031.30 | 0 Comment | |
dcoyne13 | 43.08 | 9/16/2014 |
![]() |
5Y | $1.62 | +1,090.05% | +108.77% | +981.28 | 0 Comment | |
foolerhoff | 84.59 | 1/6/2015 |
![]() |
5Y | $1.64 | +1,075.61% | +106.51% | +969.10 | 0 Comment | |
garisonmp3z | < 20 | 1/5/2015 |
![]() |
5Y | $1.67 | +1,054.49% | +104.41% | +950.08 | 0 Comment | |
new2fool23 | 44.00 | 1/5/2015 |
![]() |
1Y | $1.67 | +1,054.49% | +104.41% | +950.08 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.